Literature DB >> 14675733

Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease.

David K Simon1, Michael T Lin, Leiya Zheng, Guang-Jun Liu, Colette H Ahn, Lauren M Kim, William M Mauck, Florence Twu, M Flint Beal, Donald R Johns.   

Abstract

Oxidative damage to mitochondrial DNA (mtDNA) increases with age in the brain and can induce G:C to T:A and T:A to G:C point mutations. Though rare at any particular site, multiple somatic mtDNA mutations induced by oxidative damage or by other mechanisms may accumulate with age in the brain and thus could play a role in aging and neurodegenerative diseases. However, no prior study has quantified the total burden of mtDNA point mutation subtypes in the brain. Using a highly sensitive cloning and sequencing strategy, we find that the aggregate levels of G:C to T:A and T:A to G:C transversions and of all point mutations increase with age in the frontal cortex (FCtx). In the substantia nigra (SN), the aggregate levels of point mutations in young controls are similar to the levels in the SN or FCtx of elderly subjects. Extrapolation from our data suggests an average of 2.7 (FCtx) to 3.2 (SN) somatic point mutations per mitochondrial genome in elderly subjects. There were no significant differences between Parkinson's disease (PD) patients and age-matched controls in somatic mutation levels. These results indicate that individually rare mtDNA point mutations reach a high aggregate burden in FCtx and SN of elderly subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675733     DOI: 10.1016/s0197-4580(03)00037-x

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  42 in total

1.  Amyloid, tau, and cell death in Alzheimer's disease.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-08-26

Review 2.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

Review 3.  The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?

Authors:  Hirokazu Fukui; Carlos T Moraes
Journal:  Trends Neurosci       Date:  2008-04-09       Impact factor: 13.837

4.  Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Authors:  David K Simon; Nathan Pankratz; Diane K Kissell; Michael W Pauciulo; Cheryl A Halter; Alice Rudolph; Ronald F Pfeiffer; William C Nichols; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2010-04-01       Impact factor: 2.103

Review 5.  Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

Authors:  Ruben K Dagda; Jianhui Zhu; Charleen T Chu
Journal:  Mitochondrion       Date:  2009-06-27       Impact factor: 4.160

Review 6.  The role of DNA base excision repair in brain homeostasis and disease.

Authors:  Mansour Akbari; Marya Morevati; Deborah Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2015-05-01

Review 7.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 8.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

9.  Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease.

Authors:  Lonnie Schneider; Jianhua Zhang
Journal:  Mol Neurodegener       Date:  2010-04-13       Impact factor: 14.195

10.  DNA damage induces nuclear translocation of parkin.

Authors:  Shyan-Yuan Kao
Journal:  J Biomed Sci       Date:  2009-07-17       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.